Literature DB >> 7041537

Treatment of lumbo-ischialgias of different origins by intradiscal injection of chymopapain (discolysis). Analysis of literature and personal experiences.

F Loew, K Loew, R Kivelitz.   

Abstract

An analysis is given of a series of 25 patients suffering from lumboischialgic pain of different causes, which have been treated by discolysis. Literature reports are taken into consideration. As a result of analysis, the following statements seem justified: In no kind of lumbar disc prolapse are the results of discolysis superior to those of modern operative treatment. Discolysis results are indisputably worse in cases with the usual operative indication, which consists of neurological deficit and large disc prolapse. Favourable results by discolysis can be obtained in cases with disc protrusion or small prolapse, but these cases can mostly be cured also by consequent conservative treatment. Contraindications are marked neurological deficit, demonstration of a large disc prolapse by contrast methods, Verbiest's stenosis of the lumbar spinal canal, low back pain and ischialgia without possible proof of a disc protrusion, cases with low back pain as the main or only feature, spondylolisthesis. Disc prolapse recurrences after discolysis often occur about one month afterwards. Structural instability at this stage is likely. Therefore, as with postoperative treatment, it is advisable to avoid major physical stress for the first weeks after discolysis. Major complications after discolysis are possible, and have occurred. Because discolysis offers no real advantages but some shortcomings compared to conservative treatment for disc protrusions, and to operative treatment in real disc prolapses, its justification seems more than questionable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041537     DOI: 10.1007/bf01740073

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  26 in total

Review 1.  Chymopapain treatment of intervertebral disc disease.

Authors:  C Watts; R Knighton; G Roulhac
Journal:  J Neurosurg       Date:  1975-04       Impact factor: 5.115

2.  Backache and sciatica. A report of 90 patients treated by intradiscal injection of chymopapain (discase).

Authors:  C E Graham
Journal:  Med J Aust       Date:  1974-01-05       Impact factor: 7.738

3.  The biochemical changes in the human intervertebral disc in degeneration and nuclear prolapse.

Authors:  A Naylor
Journal:  Orthop Clin North Am       Date:  1971-07       Impact factor: 2.472

4.  Chemonucleolysis.

Authors:  L Smith
Journal:  Clin Orthop Relat Res       Date:  1969 Nov-Dec       Impact factor: 4.176

5.  Clinical studies on chemonucleolysis.

Authors:  J E Brown
Journal:  Clin Orthop Relat Res       Date:  1969 Nov-Dec       Impact factor: 4.176

6.  Tissue response to chymopapain in different concentrations. Animal investigations on microvascular effects.

Authors:  P I Brånemark; R Ekholm; J Lundskog
Journal:  Clin Orthop Relat Res       Date:  1969 Nov-Dec       Impact factor: 4.176

7.  Treatment of protruded lumbar intervertebral discs with chymopapain (Discase).

Authors:  D Parkinson; C Shields
Journal:  J Neurosurg       Date:  1973-08       Impact factor: 5.115

8.  A comparative analysis of lumbar disk disease treated by laminectomy or chemonucleolysis.

Authors:  E J Nordby; G L Lucas
Journal:  Clin Orthop Relat Res       Date:  1973 Jan-Feb       Impact factor: 4.176

9.  Dissolution by chymopapain in vitro of tissue from normal or prolapsed intervertebral disks.

Authors:  I J Stern; L Smith
Journal:  Clin Orthop Relat Res       Date:  1967 Jan-Feb       Impact factor: 4.176

Review 10.  Inadequacies and hazards of chymopapain injections as treatment for intervertebral disc disease.

Authors:  B J Sussman
Journal:  J Neurosurg       Date:  1975-04       Impact factor: 5.115

View more
  1 in total

1.  Intradiscal collagenase for treatment of lumbar disc herniations. A comparison of clinical results and computed tomography follow-up.

Authors:  E Wintermantel; H Emde; F Loew
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.